asset,indication,phase,trial_or_program,partner,notes,source_page
AKEEGA (niraparib/abiraterone),M1 Metastatic Castration-Sensitive Prostate Cancer,,AMPLITUDE,"TESARO, an oncology-focused business within GSK",,
DARZALEX (daratumumab),Smoldering Multiple Myeloma,,AQUILA,Genmab A/S,,
DARZALEX (daratumumab),Frontline multiple myeloma transplant ineligible,,CEPHEUS,Genmab A/S,,
IMBRUVICA (ibrutinib),Frontline Chronic Lymphocytic Leukemia (I + V fixed duration),,GLOW,"Pharmacyclics, LLC, an AbbVie company",,
IMBRUVICA (ibrutinib),Frontline Mantle Cell Lymphoma,,Triangle,"Pharmacyclics, LLC, an AbbVie company",,
INLEXZO (gemcitabine intravesical system),Non Muscle Invasive Bladder Cancer,,SunRISe-1,,,
RYBREVANT (amivantamab),Frontline Non Small Cell Lung Cancer in combination with chemotherapy,,PAPILLON,,,
RYBREVANT (amivantamab),,,PALOMA-3,,Subcutaneous,
Bleximenib,"Newly Diagnosed AML, chemo ineligible in combination with Venetoclax and Azacitidine",,cAMeLot-2,,,
CARVYKTI (Ciltacabtagene autoleucel),Frontline Multiple Myeloma TNI,,CARTITUDE-5,Legend Biotech,,
CARVYKTI (Ciltacabtagene autoleucel),Frontline Multiple Myeloma Transplant Eligible vs ASCT,,CARTITUDE-6,Legend Biotech,,
ERLEADA (apalutamide),Localized Prostate Cancer,,ATLAS,Regents of California and Memorial Sload Kettering,,
ERLEADA (apalutamide),High Risk Prostate Cancer,,PROTEUS,Regents of California and Memorial Sload Kettering,,
INLEXZO (gemcitabine intravesical system),Non Muscle Invasive Bladder Cancer BCG-naïve High Risk,,SunRISe-3,,,
INLEXZO (gemcitabine intravesical system),High Risk Non Muscle Invasive Bladder Cancer BGC Experienced,,SunRISe-5,,,
JNJ-1900 (NBTXR3),Head and Neck Cancer,,,Nanobiotix,,
pasritamig,Prostate Cancer,,,,,
RYBREVANT (amivantamab),Colorectal Cancer,,ORIGAMI-2,,,
RYBREVANT (amivantamab),Colorectal Cancer 2L,,ORIGAMI-3,,,
TALVEY + TECVAYLI,Relapsed Refractory Multiple Myeloma CD38 exposed,,MonumenTAL-6,,,
TALVEY (talquetamab),Relapsed Refractory Multiple Myeloma CD38 exposed,,MonumenTAL-6,,,
TALVEY (talquetamab),Relapsed Refractory Multiple Myeloma A-CD38 Naïve,,MonumenTAL-3,,,
TAR-210 (RIS/erdafitinib),Intravesical Delivery System for Localized Bladder Cancer,,MoonRISe-1,,,
TECVAYLI (teclistamab),Multiple Myeloma 1-3PLs,,MajesTEC-3,,,
TECVAYLI (teclistamab),TE NDMM maintenance,,MajesTEC-4,,,
TECVAYLI (teclistamab),TIE NDMM in combination with DR,,MajesTEC-7,,,
TALVEY + TECVAYLI,TIE NDMM in combination with DR,,MajesTEC-7,,,
TECVAYLI (teclistamab),Relapsed Refractory Multiple Myeloma CD38 exposed,,MajesTEC-9,,,
Bleximenib,Relapsed Refractory Acute Myeloid Leukemia,,ALE1001,,,
JNJ-0683 (ARX788),Breast Cancer,,,,,
JNJ-1900 (NBTXR3),Lung Cancer,,,Nanobiotix,,
TALVEY + TECVAYLI,Relapsed Refractory Multiple Myeloma,,RedirecTT-1,,,
JNJ-0387,Solid Tumors,,,,,
JNJ-0631 (ARX305),Renal Cancer,,,,,
JNJ-1493,Hematological Malignancies,,,,,
JNJ-2638,Gastrointestinal Cancer,,,,,
JNJ-2761,Multiple Myeloma,,,,,
JNJ-3413,Lymphoma,,,,,
JNJ-4496,Hematological Malignancies,,,,,
JNJ-4680,Lung Cancer,,,,,
JNJ-4681,Hematological Malignancies,,,,,
JNJ-4916,Lung Cancer,,,,,
JNJ-5322,Multiple Myeloma,,,,,
JNJ-6420,Prostate Cancer,,,,,
JNJ-7446,Lung Cancer,,,,,
JNJ-8177 (ARX517),Prostate Cancer,,,,,
JNJ-8377,Lymphoma,,,,,
JNJ-8543,Hematological Malignancies,,,,,
JNJ-9401,Prostate Cancer,,,,,
JNJ-9530,Hematological Malignancies,,,,,
JNJ-9892,Hematological Malignancies,,,,,
JNJ-9968,Hematological Malignancies,,,,,
icotrokinra,Psoriasis,,ICONIC,,,
SIMPONI (golimumab),Pediatric Ulcerative Colitis,,PURSUIT 2,"Schering-Plough (Ireland) Company, a subsidiary of Merck & Co., Inc. and Mitsubishi Tanabe Pharma Corporation",,
STELARA (ustekinumab),Pediatric Crohn's Disease,,UNITI JR,,,
STELARA (ustekinumab),Pediatric Ulcerative Colitis,,UNIFI JR,,,
TREMFYA (guselkumab),Pediatric Juvenile Psoriatic Arthritis,,,MorphoSys AG,,
TREMFYA (guselkumab),Pediatric Psoriasis,,PROTOSTAR,MorphoSys AG,,
TREMFYA (guselkumab),Psoriatic Arthritis Structural Damage,,APEX,MorphoSys AG,,
TREMFYA (guselkumab),Ulcerative Colitis Subcutaneous Induction,,ASTRO,MorphoSys AG,,
icotrokinra,Psoriatic Arthritis,,,,,
nipocalimab,Warm Autoimmune Hemolytic Anemia,,ENERGY,,,
nipocalimab,Sjogren's Disease,,,,,
nipocalimab,Hemolytic Disease of the Fetus and Newborn,,AZALEA,,,
nipocalimab,Fetal and Neonatal Alloimmune Thrombocytopenia,,FREESIA,,,
TREMFYA (guselkumab),Pediatric Ulcerative Colitis,,QUASAR JR,MorphoSys AG,,
icotrokinra,Ulcerative Colitis,,,,,
JNJ-4804 Co-antibody Therapy,Ulcerative Colitis,,,,,
JNJ-4804 Co-antibody Therapy,Psoriatic Arthritis,,,,,
JNJ-4804 Co-antibody Therapy,Crohn's Disease,,,,,
JNJ-5939,Atopic Dermatitis,,,,,
nipocalimab,Systemic Lupus Erythematosus,,,,,
nipocalimab,Idiopathic Inflammatory Myopathy,,,,,
JNJ-5108,Immunological Diseases,,,,,
JNJ-6848,Immunological Diseases,,,,,
JNJ-7528,Atopic Dermatitis,,,,,
CAPLYTA (lumateperone),Adjunctive Treatment for Major Depressive Disorder,,,,,
IMAAVY (nipocalimab),Generalized Myasthenia Gravis,,Vivacity MG3,,,
IMAAVY (nipocalimab),Generalized Myasthenia Gravis Pediatrics,,VIBRANCE MG,,,
SPRAVATO (esketamine),Treatment Resistant Depression monotherapy,,TRD4005,,,
CAPLYTA (lumateperone),Bipolar Mania,,,,,
CAPLYTA (lumateperone),Pediatric Psychiatric Indications,,,,,
nipocalimab,Chronic Inflammatory Demyelinating Polyneuropathy,,ARISE,,,
RPGR Gene Therapy,Retinitis Pigmentosa,,LUMEOS,UCL Business Plc,AAV-RPGR,
seltorexant,Adjunctive Treatment for Major Depressive Disorder with Insomnia Symptoms,,OARS,,,
ITI-1284,Generalized Anxiety Disorder,,,,,
ITI-1284,Alzheimer's Disease-Related Psychosis,,,,,
ITI-1284,Alzheimer's Disease-Related Agitation,,,,,
JNJ-1887 sCD59,Geographic Atrophy,,,Hemera Biosciences,,
JNJ-2056 (tau active immunotherapy),Alzheimer's Disease,,RETAIN,AC Immune SA,AC Immune ACI-35.030,
JNJ-5120,Major Depressive Disorder,,,,,
posdinemab,Alzheimer's Disease,,AUTONOMY,,,
SPRAVATO (esketamine),Major Depressive Disorder with Suicidal Ideation Pediatrics,,,,,
CABENUVA,HIV Adolescents,,,ViiV Healthcare,,
UPTRAVI (selexipag),Pediatric Pulmonary Arterial Hypertension,,SALTO,Nippon Shinyaku,,
macitentan,Pulmonary Arterial Hypertension 75mg,,UNISUS,Nippon Shinyaku,,
milvexian (Factor Xla),Secondary Stroke Prevention,,,Bristol Myers Squibb,,
milvexian (Factor Xla),Acute Coronary Syndrome,,,Bristol Myers Squibb,,
milvexian (Factor Xla),Atrial Fibrillation,,,Bristol Myers Squibb,,
SIRTURO,Leprosy,,,,,
SIRTURO,Tuberculosis Long Acting,,,,,
